Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closureInterim analysis planned ...

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure Interim analysis planned after 65% of patients complete treatment, expected in ...

YAVNE, Israel, Feb. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics ...

MediWound’s first drug, NexoBrid®, is an FDA- and EMA-approved orphan biologic for eschar removal in deep partial-thickness and/or full-thickness thermal burns, significantly reducing the need ...

MediWound (MDWD) shares ended the last trading session 8.5% higher at $19.83. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This ...

the scald burns epithelialized twice as rapidly and with less eschar formation. [45] Other silicone products from this company include a silicone tape, silicone foam dressings, and cotton ...

The skin serves as the body's primary defense against harmful microorganisms, toxins, and physical damage. However, severe ...

Skin grafting is a surgical procedure for treating burns, traumatic injuries ... Like tilapia skin, milkfish skin helps the wound recover faster and protects it from contamination as it prevents ...

After 14 years, the City of Philadelphia will reexamine the case of Ellen Greenberg, a teacher whose 2011 death was ruled a suicide after she was found with nearly two dozen stab wounds and ...

Ukrainian President Volodymyr Zelensky shakes hands with CIA Director Bill Burns in Kyiv last month. (Ukrainian presidential press service/AFP/Getty Images) No one would ever refer to CIA Director ...